from UCSF--preclinical efficacy (with her2+ cell lines) and phaseI going on phase II

[heblaj01]

In this informative link (http://www.bionovo.com/media/mediaar..._Treatment.pdf)
besides the original procedure to for the raw extract of BZL101 from the plant one can find the results of a test of the efficacy of BZL101 on various cancer cell lines:
HER2 negative cell lines:

MDA-MB468 +++
Du4475 ++++
MDA-MB231 ++
MDA-MB435 -
MCF7 -

HER2 positive cell lines:
BT474 +
MDA-MB453 +
MDA-MB361 +
SKBR3 ++

It should be noted that the above results are for only one of the known mode of action (DNA fragmentation induced by BZL101).
The meaning of the + sign:
Cells were treated with BZL101 at 1:100 dilution for 2 days, after which cells were analyzed for DNA content by flow cytometry. +:5–10% cells with fragmented DNA; ++: 10–20%; +++: 20–30%; ++++: more than 40%.